306 related articles for article (PubMed ID: 11379318)
1. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
Yokoyama K; Mitomi H; Kobayashi K; Katsumata T; Saigenji K; Okayasu I
Hepatogastroenterology; 2001; 48(38):401-7. PubMed ID: 11379318
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
4. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
5. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
6. Nodular duodenitis involving CD8+ cell infiltration in patients with ulcerative colitis.
Honma J; Mitomi H; Murakami K; Igarashi M; Saigenji K; Toyama K
Hepatogastroenterology; 2001; 48(42):1604-10. PubMed ID: 11813583
[TBL] [Abstract][Full Text] [Related]
7. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
8. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease.
Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P
Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of HLA-DR expression in superficial epithelium and in lamina propria of colonic mucosa in children with Crohn's disease and nonspecific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(2):143-51. PubMed ID: 9814381
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens in inflammatory bowel disease.
Smolen JS; Gangl A; Polterauer P; Menzel EJ; Mayr WR
Gastroenterology; 1982 Jan; 82(1):34-8. PubMed ID: 6796456
[TBL] [Abstract][Full Text] [Related]
11. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis.
Yao K; Yao T; Iwashita A; Matsui T; Kamachi S
Am J Gastroenterol; 2000 Aug; 95(8):1967-73. PubMed ID: 10950044
[TBL] [Abstract][Full Text] [Related]
12. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
[TBL] [Abstract][Full Text] [Related]
13. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
[TBL] [Abstract][Full Text] [Related]
14. Early changes in rectal nitric oxide and mucosal inflammatory mediators in Crohn's colitis in response to infliximab treatment.
Ljung T; Axelsson LG; Herulf M; Lundberg JO; Hellström PM
Aliment Pharmacol Ther; 2007 Apr; 25(8):925-32. PubMed ID: 17402996
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody 1F10 immunoreactivity in inflammatory bowel disease: a new marker specific only for continuous endothelial cells.
Lügering N; Stoll R; Holzgreve A; Winde G; Sorg C; Domschke W
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):777-81. PubMed ID: 7496869
[TBL] [Abstract][Full Text] [Related]
16. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC
Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414
[TBL] [Abstract][Full Text] [Related]
17. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA
J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of nitric oxide synthase by human umbilical vein endothelial cells: the effect of fetal plasma from pregnancy with umbilical placental vascular disease.
Wang X; Wang J; Trudinger B
BJOG; 2003 Jan; 110(1):53-8. PubMed ID: 12504936
[TBL] [Abstract][Full Text] [Related]
19. The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein.
Broeders MA; Doevendans PA; Maessen JG; van Gorsel E; Egbrink MG; Daemen MJ; Tangelder GJ; Reneman RS; van der Zee R
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):305-9. PubMed ID: 11479503
[TBL] [Abstract][Full Text] [Related]
20. Characterization of incisional wound healing in inducible nitric oxide synthase knockout mice.
Most D; Efron DT; Shi HP; Tantry US; Barbul A
Surgery; 2002 Nov; 132(5):866-76. PubMed ID: 12464872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
